title: Push/pull hemodiafiltration: technical aspects and clinical effectiveness.
abstract: Push/pull hemodiafiltration (HDF) is characterized by alternate repetition of filtration and backfiltration during hemodialysis with high-flux membrane. In the pressure-controlled push/pull (PC P/P) HDF system, which is the newest push/pull HDF system, there are about 25 repetitions of dilution and concentration of the blood while it passes through the hemodiafilter. Hence, the PC P/P is functionally close to the predilution mode of on-line HDF. In the PC P/P, body fluid is replaced usually by more than 120 L of dialysate during the 4 h treatment. In selecting a hemodiafilter for PC P/P, one must be certain that the blood flow channels in the hemodiafilter do not collapse by the positive pressure on the dialysate side in the backfiltration phase. Thus, the polyacrylonitrile hollow-fiber hemodiafilter and polysulfon hollow-fiber hemodiafilter are suitable for PC P/P. In the short term, PC P/P has been reported to be effective against joint pain, itchiness, insomnia, irritability, and restless leg syndrome experienced by hemodialysis patients. Midterm clinical effectiveness of PC P/P includes the requisite lowering of the erythropoietin dose and improvement in skin pigmentation. The albumin loss per treatment with the PC P/P was significantly lower than that with the conventional HDF approach when a protein-permeable membrane is used. In terms of the removal rate of prolactin, no significant difference was found between PC P/P and conventional HDF. On the other hand, the removal rates of myoglobin and beta2M, where molecular size was smaller than prolactin, was significantly greater with the PC P/P than with conventional HDF.
authors.affiliation: Deaprtment of Internal Medicine, Daiko Medical Center, Nagoya University, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Miwa
authors.forename: T
authors.initials: T
authors.lastname: Shinzato
mesh_terms: D004867:Equipment Design; D017583:Hemodiafiltration / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D008567:Membranes, Artificial; D011312:Pressure; D006435:Renal Dialysis / Q000009:adverse effects
chemical_list: D008567:Membranes, Artificial